EPO Applications Up 4%, Led by Digital Communication and Computer Technology, 5.5% Rise in U.S. Applicants
“U.S. entities also featured prominently in medical technology, accounting for 40% of all patent applications in this sector, pharmaceuticals and biotechnology.” Patent applications filed at the European Patent Office (EPO) rose 4% to 181,406 in 2019, driven by substantial increases from Chinese, Korean and U.S. applicants, according to a report published by the Office yesterday. The United States was the number one country of residence of applicants, with 46,201 applications—a rise of 5.5%. This accounted for 25% of all European patent applications. The U.S. was followed by Germany and Japan. Applications from the People’s Republic of China increased by 29.2% to 12,247 putting the country in...
Continue reading